Cargando…
Random pharmacokinetic profiles of EC-MPS in children with autoimmune disease
BACKGROUND: Therapy with mycophenolate mofetil (MMF) has become a valuable therapeutic option in children with autoimmune disease. MMF prescription in children with autoimmune diseases differs from that in transplant recipients in terms of different dosing regimen, and concomitant administration of...
Autores principales: | Filler, Guido, Sharma, Ajay Parkash, Levy, Deborah M, Yasin, Abeer |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819250/ https://www.ncbi.nlm.nih.gov/pubmed/20047676 http://dx.doi.org/10.1186/1546-0096-8-1 |
Ejemplares similares
-
PTHrP-related Hypercalcaemia in Infancy and Congenital Anomalies of the Kidney and Urinary Tract (CAKUT)
por: Kodous, Nardeen, et al.
Publicado: (2015) -
Fibroblast growth factor-23 and calcium phosphate product in young chronic kidney disease patients: a cross-sectional study
por: Yasin, Abeer, et al.
Publicado: (2013) -
Renal Function and NODM in De Novo Renal Transplant Recipients Treated with Standard and Reduced Levels of Tacrolimus in Combination with EC-MPS
por: Chan, Laurence, et al.
Publicado: (2012) -
Differences in MPS I and MPS II Disease Manifestations
por: Hampe, Christiane S., et al.
Publicado: (2021) -
EC-18 prevents autoimmune arthritis by suppressing inflammatory cytokines and osteoclastogenesis
por: Park, Jin-Sil, et al.
Publicado: (2022)